Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29. Review.

2.

Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.

Hero M, Tommiska J, Vaaralahti K, Laitinen EM, Sipilä I, Puhakka L, Dunkel L, Raivio T.

Fertil Steril. 2012 May;97(5):1242-7. doi: 10.1016/j.fertnstert.2012.02.020. Epub 2012 Mar 9.

PMID:
22405597
3.

Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.

Sipilä I, Sintonen H, Hietanen H, Apajasalo M, Alanne S, Viita AM, Leinonen E.

Acta Paediatr. 2010 Nov;99(11):1712-8. doi: 10.1111/j.1651-2227.2010.01904.x. Epub 2010 Jul 5.

PMID:
20545932
4.

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.

Walter M, Philotheou A, Bonnici F, Ziegler AG, Jimenez R; NBI-6024 Study Group.

Diabetes Care. 2009 Nov;32(11):2036-40. doi: 10.2337/dc09-0449. Epub 2009 Aug 18.

5.

Evaluation of on-farm biological treatment processes for wastewaters from vegetable peeling.

Lehtoa M, Sipilä I, Sorvala S, Hellstedt M, Kymäläinen HR, Sjöberg AM.

Environ Technol. 2009 Jan;30(1):3-10. doi: 10.1080/09593330802417019.

PMID:
19213460
6.

European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens.

Phillip M, Lebenthal Y, Lebl J, Zuckerman-Levin N, Korpal-Szczyrska M, Marques JS, Steensberg A, Jons K, Kappelgaard AM, Ibanez L; European Norditropin SGA Study Group.

Horm Res. 2009 Jan;71(1):52-9. doi: 10.1159/000173742. Epub 2008 Nov 27.

PMID:
19039237
7.

Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.

Mäkinen A, Härkönen T, Ilonen J, Knip M; Finnish Pediatric Diabetes Register.

Eur J Endocrinol. 2008 Jul;159(1):19-26. doi: 10.1530/EJE-07-0853.

8.

Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database.

Raaijmakers R, Noordam C, Karagiannis G, Gregory JW, Hertel NT, Sipilä I, Otten BJ.

J Pediatr Endocrinol Metab. 2008 Mar;21(3):267-73.

PMID:
18540254
9.

Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets.

Makitie O, Toiviainen-Salo S, Marttinen E, Kaitila I, Sochett E, Sipila I.

Horm Res. 2008;69(4):212-20. doi: 10.1159/000113021. Epub 2008 Jan 21.

PMID:
18204268
10.

Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells.

Otonkoski T, Jiao H, Kaminen-Ahola N, Tapia-Paez I, Ullah MS, Parton LE, Schuit F, Quintens R, Sipilä I, Mayatepek E, Meissner T, Halestrap AP, Rutter GA, Kere J.

Am J Hum Genet. 2007 Sep;81(3):467-74. Epub 2007 Jul 26.

11.

Bone health in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED): findings in 25 adults.

Mäkitie O, Sochett EB, Bondestam S, Sipilä I, Perheentupa J.

Clin Endocrinol (Oxf). 2006 May;64(5):489-94.

PMID:
16649965
12.

Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.

Hertel NT, Eklöf O, Ivarsson S, Aronson S, Westphal O, Sipilä I, Kaitila I, Bland J, Veimo D, Müller J, Mohnike K, Neumeyer L, Ritzen M, Hagenäs L.

Acta Paediatr. 2005 Oct;94(10):1402-10.

PMID:
16299871
13.

Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow-up case-series study.

Pynnönen PA, Isometsä ET, Verkasalo MA, Kähkönen SA, Sipilä I, Savilahti E, Aalberg VA.

BMC Psychiatry. 2005 Mar 17;5:14.

14.

Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome.

Piippo S, Lenko H, Kainulainen P, Sipilä I.

J Clin Endocrinol Metab. 2004 Jul;89(7):3241-7.

PMID:
15240598
15.

[Novel insulin products and delivery methods].

Sipilä I, Saukkonen T.

Duodecim. 2004;120(9):1167-72. Review. Finnish. No abstract available.

PMID:
15232860
16.

[The criteria for good care of children and adolescents with diabetes].

Komulainen J, Lounamaa R, Sipilä I, Knip M.

Duodecim. 2004;120(9):1135-7. Review. Finnish. No abstract available.

PMID:
15232856
17.

Growth hormone treatment in Aarskog syndrome: analysis of the KIGS (Pharmacia International Growth Database) data.

Darendeliler F, Larsson P, Neyzi O, Price AD, Hagenäs L, Sipilä I, Lindgren AC, Otten B, Bakker B; KIGS International Board.

J Pediatr Endocrinol Metab. 2003 Oct-Nov;16(8):1137-42.

PMID:
14594174
18.

HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families.

Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipilä I, Akerblom HK, Ilonen J.

Tissue Antigens. 2003 Aug;62(2):162-9.

PMID:
12889996
19.
20.

Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release.

Otonkoski T, Kaminen N, Ustinov J, Lapatto R, Meissner T, Mayatepek E, Kere J, Sipilä I.

Diabetes. 2003 Jan;52(1):199-204.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk